Cannabis and mental illness in adolescents: a review

References

• United Nations Office on Drugs and Crime. World Drug Report 2008. Vienna: United Nations, Publication UNODC. 2008. Available from: wwwUNODC.org
   Google Scholar
• Peltzer K, Ramlagan S. Cannabis use trends in South Africa. S A J Psych. 2007;13(4):126–31.
   Web of Science ®Google Scholar
• Moore TH, Zammit S, Lingford Hughes A, et al. Effects of cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319–28.10.1016/S0140-6736(07)61162-3
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Poulten R, et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325:1212–3.10.1136/bmj.325.7374.1212
   PubMed Web of Science ®Google Scholar
• Chadwick B, Miller ML, Hurd YL. Cannabis use during adolescent development: susceptibility to psychiatric illness. Front Psychiatry. 2013;4:129. doi: 10.3389/fpsyt.2013.00129
   PubMedGoogle Scholar
• Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98(11):1493–504.10.1046/j.1360-0443.2003.00437.x
   PubMed Web of Science ®Google Scholar
• Van Heerden SM, Grimsrud A, Seedat S, et al. Patterns of substance use in South Africa: results from the South African Stress and Health survey. S A Med J. 2009;99:358–66.
   PubMed Web of Science ®Google Scholar
• Peltzer K, Ramlagan S, Johnson BD. Phaswana- Mafuya N. Illicit drug use and treatment in South Africa: a review. Subst Use Misuse. 2010;45(13):221–43.
   Web of Science ®Google Scholar
• Paruk S, Ramlall S, Burns JK. Adolescent onset psychosis — a 2 year retrospective study of adolescents admitted to a general psychiatric unit. S A J Psych. 2009;15(4):86–92.
   Web of Science ®Google Scholar
• Lachman A, Nassen R, Hawkridge S, et al. A retrospective chart review of the clinical and psychosocial profile of psychotic adolescents with co-morbid substance use disorders presenting to acute adolescent psychiatric services at Tygerberg Hospital. S A J Psych. 2012;18(2):53–60.
   Web of Science ®Google Scholar
• Rach Beisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatric Services. 1999;50(11):1427–34.
   PubMed Web of Science ®Google Scholar
• James A, James C, Thwaites T. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry Res: Neuroimaging. 2013 [cited 2013 Nov 12]. Available from: (article in press-http://dx.doi/org/10.1016/j.psychresns.2013.07.12
   Google Scholar
• Bossong MG, Niesink RJ. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis induced schizophrenia. Progress in Neurobiol. 2010;92:370–85.10.1016/j.pneurobio.2010.06.010
   PubMed Web of Science ®Google Scholar
• Parakh P, Basu D. Cannabis and psychosis: have we found the missing links? Asian J Psych. 2013;6:281–7.10.1016/j.ajp.2013.03.012
   PubMedGoogle Scholar
• Leeson VC, Harrison I, Ron MA, et al. The effect of cannabis use and cognitive reserve on age of onset and psychosis outcomes in first-episode schizophrenia. Schizophr Bull. 2011;15338(4):873–80.
   Google Scholar
• Schimmelmann BG, Conus P, Cotton SM, et al. Cannabis use disorder and age of onset of psychosis — a study in first episode patients. Schizophr Res. 2011;129(1):52–6.10.1016/j.schres.2011.03.023
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Poulten R, et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325(7374):1212–3.10.1136/bmj.325.7374.1212
   PubMed Web of Science ®Google Scholar
• Estrada G, Fatjó-Vilas M, Muñoz MJ, et al. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatr Scand. 2011;123(6):485–92.10.1111/acps.2011.123.issue-6
   PubMed Web of Science ®Google Scholar
• Stefanis NC, Dragovic M, Power BD, et al. Age at initiation of cannabis use predicts age at onset of psychosis: 7-8 year trend. Schizophr Bull. 2013;39(2):251–4. doi: 10.1093/schbul/sbs18810.1093/schbul/sbs188
   PubMed Web of Science ®Google Scholar
• González-Pinto A, Vega P, Ibáñez B, et al. Impact of cannabis and other drugs on age at onset of psychosis. J Clin Psychiatry. 2008;69(8):1210–6.10.4088/JCP.v69n0802
   PubMed Web of Science ®Google Scholar
• Baeza I, Graell M, Moreno D, et al. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short term outcome (CAFEPS study). Schizophr Res. 2009;113:129–37.10.1016/j.schres.2009.04.005
   PubMed Web of Science ®Google Scholar
• Large M, Sharma S, Compton MT, et al. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011;68(6):555–61. doi:10.1001/archgenpsychiatry.2011.510.1001/archgenpsychiatry.2011.5
   PubMed Web of Science ®Google Scholar
• Jeppesen P, Petersen L, Thorup A, et al. The association between premorbid adjustment, duration of untreated psychosis and outcome in first episode psychosis. Psychol Med. 2008;38(8):1157–66.
   PubMed Web of Science ®Google Scholar
• Burns JK. Pathways from cannabis to psychosis: a review of the evidence. Front Psychiatry. 2013;4:128. doi: 10.3389/fpsyt.2013.00128
   PubMedGoogle Scholar
• Schimmelmann BG, Conus P, Cotton S, et al. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur Psychiatry. 2012;27(6):463–9.10.1016/j.eurpsy.2011.03.001
   PubMed Web of Science ®Google Scholar
• Lagerberg TV, Kvitland L, Aminoff SR, et al. Indications of a dose relationship between cannabis use and age at onset in bipolar disorder. Psychiatry Res. 2013;215(1):101–4. Available from: http://dx.doi.org/10.1016/j.psychres.2013.10.29
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Fröhlich C, Behrendt S, et al. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10 year prospective longitudinal community study in adolescents. Drug Alcohol Depend. 2007; 88(1):S60–70.10.1016/j.drugalcdep.2006.12.013
   Google Scholar
• Rey JM, Martin A, Krabman P. Is the party over? Cannabis and juvenile psychiatric disorders: the past 10 years. J Am Acad Child Adolesc Psychiatry. 2004;43(10):1194–205.10.1097/01.chi.0000135623.12843.60
   PubMed Web of Science ®Google Scholar
• Patton GC, Coffey C, Carlin JB, et al. Cannabis use and mental health in young people cohort study. BMJ. 2002;325(7374):1195–8.10.1136/bmj.325.7374.1195
   PubMed Web of Science ®Google Scholar
• Van Ours JC, Williams J, Fergusson D, et al. Cannabis use and suicidal ideation. J Health Econ. 2013;32:524–37.10.1016/j.jhealeco.2013.02.002
   PubMed Web of Science ®Google Scholar
• Viveros MP, Marco EM, File SE. Endocannibinoid system and stress and anxiety response. Pharmacol Biochem Behav. 2005;81(2):331–42.10.1016/j.pbb.2005.01.029
   PubMed Web of Science ®Google Scholar
• Grant I, Gonzalez R, Carey CL, et al. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc. 2003;9:679–89. doi: 10.1017/S1355617703950016
   PubMed Web of Science ®Google Scholar
• Rabin RA, Zakzanis KK, George TP. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr Res. 2011;128(1-3):111–6 doi:10.1016/j.schres.2011.02.01710.1016/j.schres.2011.02.017
   PubMed Web of Science ®Google Scholar
• Kumra S, Robinson P, Tambyraja R, et al. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. J Am Acadof Child Adolescent Psychiatry. 2012;51(2):171–80.10.1016/j.jaac.2011.11.001
   PubMed Web of Science ®Google Scholar
• Kolliakou A, Joseph C, Ismail K, et al. Why do patients with psychosis use cannabis and are they ready to change their use? Int J Deve Neurosci. 2011;29:335–46.10.1016/j.ijdevneu.2010.11.006
   PubMed Web of Science ®Google Scholar
• Gregg L, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis. Clin Psychology Rev 2007;27(4):494–510.10.1016/j.cpr.2006.09.004
   PubMed Web of Science ®Google Scholar
• Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of aetiological theories. Addictive Behav. 1998;23: 717–34.10.1016/S0306-4603(98)00073-2
   PubMed Web of Science ®Google Scholar
• Resnik MD, Bearman PS, Blum RW, et al. Protecting adolescents from harm: findings from the National Longitude study on Adolescent health. JAMA. 1997;278:823–32.
   PubMed Web of Science ®Google Scholar
• Dickey B, Azeni H, Weiss R, et al. Schizophrenia, substance use disorders and medical co-morbidity. J Mental Health Policy Econ. 2000;3: 27–33.10.1002/(ISSN)1099-176X
   PubMedGoogle Scholar
• Bakare MO, Agomoh AO, Ebigbo PO, et al. Co-morbid disorders and sexual risk behavior in Nigerian adolescents with bipolar disorder. Int Arch Med. 2009;2(1):16. doi: 10.1186/1755-7682-2-16.10.1186/1755-7682-2-16
   PubMedGoogle Scholar